Sana Biotechnology, Inc. (SANA)
3.835
-0.04
(-0.90%)
USD |
NASDAQ |
Sep 01, 16:00
3.835
0.00 (0.00%)
After-Hours: 17:26
Sana Biotechnology Total Long Term Debt (Quarterly) : 59.23M for June 30, 2026
Total Long Term Debt (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Long Term Debt (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 59.23M |
| March 31, 2026 | 60.45M |
| December 31, 2025 | 63.92M |
| September 30, 2025 | 67.87M |
| June 30, 2025 | 71.66M |
| March 31, 2025 | 78.31M |
| December 31, 2024 | 81.66M |
| September 30, 2024 | 85.48M |
| June 30, 2024 | 88.56M |
| March 31, 2024 | 92.92M |
| December 31, 2023 | 90.90M |
| September 30, 2023 | 83.37M |
| June 30, 2023 | 100.24M |
| Date | Value |
|---|---|
| March 31, 2023 | 101.61M |
| December 31, 2022 | 95.86M |
| September 30, 2022 | 99.86M |
| June 30, 2022 | 102.96M |
| March 31, 2022 | 102.52M |
| December 31, 2021 | 101.78M |
| September 30, 2021 | 92.40M |
| June 30, 2021 | 66.15M |
| March 31, 2021 | 66.35M |
| December 31, 2020 | 68.20M |
| March 31, 2020 | 0.00 |
| December 31, 2019 | 46.36M |
Total Long Term Debt Definition
Represents a company's total debt maturing for more than 12 months of the reporting period.
Total Long Term Debt (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Long Term Debt (Quarterly) Benchmarks
| Twist Bioscience Corp. | 84.96M |
| Beam Therapeutics, Inc. | 232.15M |
| Prime Medicine, Inc. | 103.51M |
| Intellia Therapeutics, Inc. | 50.07M |
| Moderna, Inc. | 1.266B |